Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care.
This work was undertaken by the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland (APM) as a demonstration project in developing clinical guidelines relevant to palliative care from a pragmatic approach to literature review and grading of clinical evidence. CANCERLIT and Embase were searched for relevant papers written in English, published since 1980. Each study identified was rated against agreed criteria for levels of evidence. Most studies were not specifically designed to define speed of response, and were not undertaken in palliative care patients. Thus, careful reading and grading of each study was necessary. Sufficient evidence was identified to make recommendations for clinical practice in a palliative care population of patients, and areas for future research have been identified. Bisphosphonates appear to have a role in managing pain from metastases which has been refractory to conventional analgesic management and where oncological or orthopaedic intervention is delayed or inappropriate.
Mannix
K
K
Marie Curie Centre, Marie Curie Drive, Newcastle upon Tyne NE4 6SS, UK. agreen@newcastlecentre.mariecurie.org.uk
Ahmedzai
S H
SH
Anderson
H
H
Bennett
M
M
Lloyd-Williams
M
M
Wilcock
A
A
D001859:Bone Neoplasms / Q000556:secondary*; D001943:Breast Neoplasms; D004164:Diphosphonates / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D009101:Multiple Myeloma; D010146:Pain / Q000517:prevention & control*; D010166:Palliative Care / Q000592:standards; D017410:Practice Guidelines as Topic; D011471:Prostatic Neoplasms
D004164:Diphosphonates